GGrantIndex
← Leaderboards

Bankole A Johnson

University Of Texas Hlth Sci Ctr San Ant

Google Scholar ↗PubMed ↗ORCID ↗
$31,821,485
Attributed
$37,327,762
Total exposure
23
Grants
16
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.3M · FY2005–19
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19

Funding mix

By agency

NIH$37,327,762 · 23

By mechanism

R01$31,896,672 · 13
M01$2,532,829 · 7
U10$1,983,246 · 1
RC1$671,415 · 1
N01$243,600 · 1

Top collaborators

Most similar at University Of Texas Hlth Sci Ctr San Ant

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Trials”

Research focus

Clinical TrialsHuman SubjectClinical ResearchHuman Therapy EvaluationAlcoholism /Alcohol AbusePharmaceutical PreparationsPlacebosAlcohol DependenceOndansetronDrinkingTopiramateDouble-Blind MethodRandomizedCravingPsychosocialAlcoholism /Alcohol Abuse ChemotherapyAlcoholsPharmacogeneticsDisease /Disorder OnsetCocaineDesignDrug InteractionsPharmacotherapyBehavioral /Social Science Research Tag

Grant awards (81)

Genomic Predictors of Placebo response in Phase II AUD trials$585,949
R01 · FY2019 · AA
Pharmacogenetic Treatment with Anti-Glutaminergic Agents for Comorbid PTSD & AUD$598,446
R01 · FY2018 · AA · contact PI
Genomic Predictors of Placebo response in Phase II AUD trials$514,295
R01 · FY2018 · AA
Pharmacogenetic Treatment with Anti-Glutaminergic Agents for Comorbid PTSD & AUD$552,743
R01 · FY2017 · AA · contact PI
Pharmacogenetic Treatment with Anti-Glutaminergic Agents for Comorbid PTSD & AUD$568,402
R01 · FY2016 · AA · contact PI
New Pharmacotherapy for Alcohol and Co-morbid Disorders$827,356
R01 · FY2014 · AA
New Pharmacotherapy for Alcohol and Co-morbid Disorders$806,997
R01 · FY2013 · AA
New Pharmacotherapy for Alcohol and Co-morbid Disorders$882,510
R01 · FY2012 · AA
1/2-Pharmacogenetic Treatments for Alcoholism$543,690
R01 · FY2012 · AA · contact PI
Pharmacologic Treatments in Emerging Adults$469,711
R01 · FY2012 · AA · contact PI
Pharmacologic Treatments in Emerging Adults$193,944
R01 · FY2012 · AA · contact PI
New Pharmacotherapy for Alcohol and Co-morbid Disorders$900,625
R01 · FY2011 · AA
Pharmacologic Treatments in Emerging Adults$664,220
R01 · FY2011 · AA · contact PI
New Pharmacotherapy for Alcohol and Co-morbid Disorders$964,231
R01 · FY2010 · AA
LAB TRIALS TO DEVELOP MEDICATIONS FOR COCAINE DEPENDENCE--STUDY 1$825,906
M01 · FY2010 · RR · contact PI
Pharmacologic Treatments in Emerging Adults$671,441
R01 · FY2010 · AA · contact PI
Innovative Analytic Methods of Person-Centered Data and Adaptive Designs for Alco$334,448
RC1 · FY2010 · AA · contact PI
Pharmacologic Treatments in Emerging Adults$108,112
R01 · FY2010 · AA · contact PI
Pharmacologic Treatments in Emerging Adults$661,585
R01 · FY2009 · AA · contact PI
Novel Pharmacotherapy for Dual Dependence$485,492
R01 · FY2009 · DA · contact PI
LAB TRIALS TO DEVELOP MEDICATIONS FOR COCAINE DEPENDENCE--STUDY 1$438,707
M01 · FY2009 · RR · contact PI
Innovative Analytic Methods of Person-Centered Data and Adaptive Designs for Alco$336,967
RC1 · FY2009 · AA
CLINICAL TRIAL: NEW MEDICATIONS TO TREAT ALCOHOL DEPENDENCE$35,097
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: NEW MEDICATIONS TO TREAT ALCOHOL DEPENDENCE$715,252
M01 · FY2008 · RR · contact PI
Combining Medication Treatments for Alcoholism$648,083
R01 · FY2008 · AA · contact PI
Pharmacologic Treatments in Emerging Adults$623,286
R01 · FY2008 · AA · contact PI
Medication Development for Cocaine Dependence$579,640
R01 · FY2008 · DA · contact PI
LAB TRIALS TO DEVELOP MEDICATIONS FOR COCAINE DEPENDENCE--STUDY 1$67,217
M01 · FY2008 · RR · contact PI
Combining Medication Treatments for Alcoholism$660,785
R01 · FY2007 · AA · contact PI
Medication Development for Cocaine Dependence$591,470
R01 · FY2007 · DA · contact PI
Novel Pharmacotherapy for Dual Dependence$495,400
R01 · FY2007 · DA · contact PI
NEW MEDICATIONS TO TREAT ALCOHOL DEPENDENCE$411,591
M01 · FY2007 · RR · contact PI
New Medications to Treat Alcohol Dependence$354,065
R01 · FY2007 · AA · contact PI
Combining Medication Treatments for Alcoholism$679,589
R01 · FY2006 · AA · contact PI
Medication Development for Cocaine Dependence$606,362
R01 · FY2006 · DA · contact PI
Novel Pharmacotherapy for Dual Dependence$507,522
R01 · FY2006 · DA · contact PI
LAB TRIALS TO DEVELOP MEDICATIONS FOR COCAINE DEPENDENCE$455,145
R01 · FY2006 · DA · contact PI
New Medications to Treat Alcohol Dependence$358,426
R01 · FY2006 · AA · contact PI
NEW MEDICATIONS TO TREAT ALCOHOL DEPENDENCE$39,059
M01 · FY2006 · RR · contact PI
COMBINED PHARMACOTHERAPIES FOR ALCOHOLISM$675,043
R01 · FY2005 · AA
Combining Medication Treatments for Alcoholism$661,098
R01 · FY2005 · AA
Medication Development for Cocaine Dependence$624,015
R01 · FY2005 · DA
Novel Pharmacotherapy for Dual Dependence$524,890
R01 · FY2005 · DA
LAB TRIALS TO DEVELOP MEDICATIONS FOR COCAINE DEPENDENCE$460,181
R01 · FY2005 · DA
New Medications to Treat Alcohol Dependence$360,866
R01 · FY2005 · AA
Combining Medication Treatments for Alcoholism$638,283
R01 · FY2004 · AA
PHARMACOLOGIC TREATMENTS FOR ALCOHOLISM$618,916
R01 · FY2004 · AA
LAB TRIALS TO DEVELOP MEDICATIONS FOR COCAINE DEPENDENCE$397,076
R01 · FY2004 · DA
COMBINED PHARMACOTHERAPIES FOR ALCOHOLISM$346,780
R01 · FY2004 · AA
New Medications to Treat Alcohol Dependence$344,057
R01 · FY2004 · AA
COMBINED PHARMACOTHERAPIES FOR ALCOHOLISM$328,265
R01 · FY2004 · AA
Joint Behavior/Pharmacologic Treatment of Alcoholism$235,610
U10 · FY2004 · AA
LAB TRIALS TO DEVELOP MEDICATIONS FOR COCAINE DEPENDENCE$96,144
R01 · FY2004 · DA
PHARMACOLOGIC TREATMENTS FOR ALCOHOLISM$83,461
R01 · FY2004 · AA
COMBINED PHARMACOTHERAPIES FOR ALCOHOLISM$66,950
R01 · FY2004 · AA
Joint Behavior/Pharmacologic Treatment of Alcoholism$41,664
U10 · FY2004 · AA
PHARMACOLOGIC TREATMENTS FOR ALCOHOLISM$700,885
R01 · FY2003 · AA
COMBINED PHARMACOTHERAPIES FOR ALCOHOLISM$675,045
R01 · FY2003 · AA
Joint Behavior/Pharmacologic Treatment of Alcoholism$445,294
U10 · FY2003 · AA
LAB TRIALS TO DEVELOP MEDICATIONS FOR COCAINE DEPENDENCE$390,962
R01 · FY2003 · DA
MEDICATION DEVELOPMENT FOR METHAMPHETAMINE DEPENDENCE$296,145
R01 · FY2003 · DA
PHARMACOLOGIC TREATMENTS FOR ALCOHOLISM$700,443
R01 · FY2002 · AA
COMBINED PHARMACOTHERAPIES FOR ALCOHOLISM$674,968
R01 · FY2002 · AA
JOINT BEHAVIORAL/PHARMACOLOGIC TREATMENT OF ALCOHOLISM$420,226
U10 · FY2002 · AA
MEDICATION DEVELOPMENT FOR METHAMPHETAMINE DEPENDENCE$295,199
R01 · FY2002 · DA
COCAINE BRAIN EFFECTS AND NEUROIMAGING$281,692
R01 · FY2002 · DA
LAB TRIALS TO DEVELOP MEDICATIONS FOR COCAINE DEPENDENCE$275,809
R01 · FY2002 · DA
PHARMACOLOGIC TREATMENTS FOR ALCOHOLISM$72,744
R01 · FY2002 · AA
COMBINED PHARMACOTHERAPIES FOR ALCOHOLISM$674,845
R01 · FY2001 · AA
PHARMACOLOGIC TREATMENTS FOR ALCOHOLISM$629,100
R01 · FY2001 · AA
JOINT BEHAVIORAL/PHARMACOLOGIC TREATMENT OF ALCOHOLISM$420,226
U10 · FY2001 · AA
MEDICATION DEVELOPMENT FOR METHAMPHETAMINE DEPENDENCE$293,961
R01 · FY2001 · DA
COCAINE BRAIN EFFECTS AND NEUROIMAGING$273,613
R01 · FY2001 · DA
LAB TRIALS TO DEVELOP MEDICATIONS FOR COCAINE DEPENDENCE$269,422
R01 · FY2001 · DA
PHARMACOLOGIC TREATMENTS FOR ALCOHOLISM$640,862
R01 · FY2000 · AA
JOINT BEHAVIORAL/PHARMACOLOGIC TREATMENT OF ALCOHOLISM$420,226
U10 · FY2000 · AA
MEDICATION DEVELOPMENT FOR METHAMPHETAMINE DEPENDENCE$293,066
R01 · FY2000 · DA
COCAINE BRAIN EFFECTS AND NEUROIMAGING$265,186
R01 · FY2000 · DA
LAB TRIALS TO DEVELOP MEDICATIONS FOR COCAINE DEPENDENCE$263,178
R01 · FY2000 · DA
COLLABORATIVE RESEARCH PROJECTS ON ALCOHOL TREATMENT$243,600
N01 · FY2000 · AA
PHARMACOLOGIC TREATMENTS FOR ALCOHOLISM$144,000
R01 · FY2000 · AA